Here's What IBM's Profit Signals for AI Investors Today
IBM's latest profit warning sheds light on the strength and limits of AI demand, cloud growth, and enterprise spendin...
Vix Vs Daily Index Volatility Readings
VIX and daily volatility offer complementary views of risk. This overview explains how to interpret both for better timing and sizing.
21,595 articlesReasons SpaceX Stock Could Fall 30% by 2028: Three Risks Investors Should Watch
SpaceX has dazzled investors, but big bets come with big risks. This article explains three reasons reasons spacex st...
Travelers Companies Stock Crushed: Why TRV Surged Today
Travelers Insurance shares surged after a standout quarterly report, lifting the stock well above the market. This an...
Warren Buffett Just Confirmed Alphabet Bet: Is It a Buy?
Berkshire Hathaway's big Alphabet stake marks a rare foray into technology by Warren Buffett. This article breaks dow...
What This MannKind Director Signals Risk to Royalties
A single director's sale at MannKind raises questions about the durability of royalty streams. This analysis breaks d...
Alphabet Reports Results After Bell: Capex Decides Stock Path
Alphabet reports results after the bell, but the line that matters most might be capex. This guide shows how data-cen...
Freshworks Falls Year $7.5: What Investors Should Know
A major fund trimmed Freshworks stock by hundreds of thousands of shares, triggering a 60% year-long drop in the stoc...
Palantir Stock Now? Is It a Smart Buy in 2026 and Beyond?
Palantir has surprised and divided investors with big moves and bold AI promises. This guide explains what to watch, ...
Jackson Financial 2025 Earnings Outlook for Investors
This guide breaks down what to watch in Jackson Financial's 2025 earnings, with practical tips and real-world scenari...
Crypto Crash Playbook: High-Conviction Buys to Consider Now
Markets can tumble fast in crypto, but a disciplined plan can uncover resilient opportunities. This crypto crash play...
Could Soar These Things: 2 Catalysts for XP Stock Now
Two big catalysts could push XP stock higher: regulatory clarity in Brazil’s fintech scene and stronger cross-selling...
Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status